E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 2.94M 3.06M 3.09M 2.54M 1.87M
Total Other Revenue -- -- -- -- --
Total Revenue 2.94M 3.06M 3.09M 2.54M 1.87M
Cost of Revenue 2.06M 1.94M 2.24M 2.47M 1.52M
Gross Profit 875.40K 1.12M 850.00K 73.10K 347.40K
SG&A Expenses 786.70K 1.22M 717.20K 38.70K 510.70K
Depreciation & Amortization 25.70K -- -- -- 24.60K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.88M 3.17M 2.96M 2.45M 2.06M
Operating Income 63.10K -103.80K 132.80K 90.30K -187.90K
Income Before Tax -283.00K -377.10K -207.70K -349.80K -568.10K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -283.00K -377.10K -207.70K -349.80K -568.10K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -283.00K -377.10K -207.70K -349.80K -568.10K
EBIT 63.10K -103.80K 132.80K 90.30K -187.90K
EBITDA 322.60K 149.10K 380.50K 104.50K 70.80K
EPS Basic 0.00 0.00 0.00 0.00 -0.01
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00 -0.01
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 115.08M 105.77M 84.58M 82.56M 82.43M
Average Diluted Shares Outstanding 115.28M 105.89M 84.58M 82.56M 82.43M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings